The NHS ConfedExpo Conference. I’ve been going now for 20 years and seen firsthand the ebbs and flows of ‘the big topics’, ...

This year’s NHS ConfedExpo took place on 11–12 June at Manchester Central, bringing together around 9000 attendees. Among ...

VectorY Therapeutics has appointed Jessica Atkinson as Chief Business Officer. In this newly created role, she will support ...

The momentum behind GLP-1 receptor agonists has become impossible to ignore. Originally developed to control blood glucose in diabetes, these therapies have surged to the forefront of obesity care, ...

PMGroup Worldwide and Visions4Health have launched the Excellence in Healthcare Partnerships (EHP) Awards to recognise ...

The NHS has announced the launch of a new initiative aimed at identifying pancreatic cancer in its earliest stages. The three ...

Biocartis Group of Companies (Biocartis) has announced the appointment of Ben Svarczkopf as its new Senior Vice President ...

eXmoor Pharma and Signadori Bio have entered into a partnership aimed at advancing a gene-modified monocyte-derived ...

Teva’s experimental anti-PD1-IL2 ATTENUKINE therapy is designed to selectively deliver interleukin-2 to PD-1-expressing T ...

A new investigational treatment has shown strong and lasting responses in multiple myeloma patients with extramedullary ...

EDX Medical Group has entered into an agreement with Spire Healthcare Group to advance diagnostic innovations aimed at ...

Zusduri, which is delivered directly into the bladder in an out-patient procedure, is now the first and only medication approved by the US regulator to treat adults with recurrent low-grade ...